Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer
In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role
NCI Extends PRI’s Fredrick Contract Six Months
ODAC Okays Photofrin for Obstructive Esophageal Cancer
NIH reiterates Position On Closed Meeting Of BSC Chairmen
Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week
New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities
RFPS, RFAs Available
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
